Marketing-authorisation holder
Biocon Limited
7 medicines in 1 country, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder
7 medicines in 1 country, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| NITROFURANTOIN25mg/5ml · Suspension | Nitrofurantoin | United States | Marketed | 2011 |
| PEMETREXED DISODIUM100mg base/vial | 1gm base/vial | 500mg base/vial | 750mg base/vial · Powder | Pemetrexed | United States | Marketed | 2022 |
| SIMVASTATIN10mg | 20mg | 40mg | 5mg | 80mg · Tablet | Simvastatin | United States | Marketed | 2005 |
| CABOZANTINIB20mg | 40mg · Tablet | Cabozantinib | United States | tentative | 2025 |
| CARBIDOPA AND LEVODOPA145mg | 195mg | 23.75mg | 245mg | 48.75mg | 61.25mg | 95mg · Capsule, extended release | Carbidopa, Levodopa | United States | tentative | 2025 |
| OXCARBAZEPINE300mg | 600mg · Tablet | Oxcarbazepine | United States | tentative | 2025 |
| PEMETREXED100mg | 500mg · Injectable | Pemetrexed | United States | tentative | 2018 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 7 | 3 | 4 | CompaniesAll medicines |
Also in the registers of Brazil, Canada, Saudi Arabia
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.